Case-Control Study of the Risk Factors for Acquisition of Pseudomonas and Proteus Species during Tigecycline Therapy

Tigecycline is an important agent in clinical practice because of its broad-spectrum activity. However, it has no activity against Pseudomonas or Proteus species. We conducted a case-control study to analyze risk factors for the acquisition of Pseudomonas or Proteus spp. during tigecycline therapy....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Park, Ga Eun, Kang, Cheol-In, Wi, Yu Mi, Ko, Jae-Hoon, Lee, Woo Joo, Lee, Ji Yong, Cho, Sun Young, Ha, Young Eun, Chung, Doo Ryeon, Peck, Kyong Ran, Song, Jae-Hoon
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538539/
https://ncbi.nlm.nih.gov/pubmed/26100705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04865-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars